CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

Original citation: J Clin Invest. 2018;128(6):2613–2625. https://doi.org/10.1172/JCI98769

Citation for this retraction: J Clin Invest. 2022;132(6):e159825. https://doi.org/10.1172/JCI159825

QIMR Berghofer Medical Research Institute recently notified the JCI of concerns regarding Figures 4I and 7A and indicated that an independent panel investigation concluded that these figures contain data fabricated by Mark Smyth. In accordance with the institutional recommendation, the JCI is retracting this article.

Amelia Roman Aguilera, Matthias Braun, Ailin Lepletier, and Kyohei Nakamura have agreed with the Journal’s decision to retract the paper. The remaining authors abstained from commenting or could not be reached.

Version 1. 03/15/2022

Electronic publication